Attenuation of morphine tolerance and dependence by thymoquinone in mice

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 396

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJP-6-1_006

تاریخ نمایه سازی: 1 مهر 1398

Abstract:

Objectives: Dependence and tolerance are major restricting factors in the clinical use of opioid analgesics. In the present study, the effects of thymoquinone, the major constituent of Nigella sativa seeds, on morphine dependence and tolerance were investigated in mice. Materials and Methods: Male adult NMRI mice were made tolerant and dependent by repeated injections of morphine (50, 50, and 75 mg/kg, i.p. on 9 a.m., 1 p.m., and 5 p.m., respectively) during a 3-day administration schedule. The hot-plate test was used to assess tolerance to the analgesic effects of morphine. Naloxone (2 mg/kg, i.p.) was injected to precipitate withdrawal syndrome in order to assess the morphine dependence. To evaluate the effects of thymoquinone on tolerance and dependence to morphine, different single or repeated doses of thymoquinone were administered in mice. Rotarod was used to assess the motor coordination. Results: Administration of single or repeated doses of thymoquinone (20 and 40 mg/kg, i.p.) significantly decreased the number of jumps in morphine dependent animals. Repeated administration of thymoquinone (20 and 40 mg/kg, for 3 days) and also single injection of thymoquinone (40 mg/kg, on the fourth day) attenuated tolerance to the analgesic effect of morphine. None of the thymoquinone doses (10, 20, and 40 mg/kg) produced any antinociceptive effects on their own. Motor coordination of animals was impaired by the high dose of thymoquinone (40 mg/kg). Conclusion: Based on these results, it can be concluded that thymoquinone prevents the development of tolerance and dependence to morphine.

Authors

Hossein Hosseinzadeh

Pharmaceutical Research Center, Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Siavash Parvardeh

Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Masoudi

Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahsa Moghimi

Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Abdel-Fattah AM, Matsumoto K, Watanabe H. 2000. Antinociceptive effects of ...
  • Abdel-Zaher AO, Abdel-Rahman MS, ELwasei FM. 2010. Blockade of nitric ...
  • Abdel-Zaher AO, Abdel-Rahman MS, ELwasei FM. 2011. Protective effect of ...
  • Abdel-Zaher AO, Mostafa MG, Farghaly HSM, Hamdy MM, Abdel-Hady RH. ...
  • Ahmad A, Husain A, Mujeeb M, Alam Khan S, Najmi ...
  • Akhondian J, Kianifar H, Raoofziaee M, Moayedpour A, Toosi MB, ...
  • Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, ...
  • Al-Sheddi ES, Farshori NN, Al-Oqail MM, Musarrat J, Al-Khedhairy AA, ...
  • Babazadeh B, Sadeghnia HR, Safarpour Kapurchal E, Parsaee H, Nasri ...
  • Bashir MU, Qureshi HJ. 2010. Analgesic effect of Nigella sativa ...
  • Bhandari PR. 2014. Potential role of Nigella sativa (black cumin) ...
  • Boskabady MH, Keyhanmanesh R, Khamneh S, Ebrahimi MA. 2011. The ...
  • Boskabady MH, Kiani S, Jandaghi P. 2004. Stimulatory effect of ...
  • Boskabady MH, Mohsenpoor N, Takaloo L. 2010. Antiasthmatic effect of ...
  • Bourgou S, Pichette A, Marzouk B, Legault J. 2012. Antioxidant, ...
  • Cikman O, Ozkan A, Aras AB, Soylemez O, Alkis H, ...
  • Contet C, Kieffer BL, Befort K. 2004. Mu opioid receptor: ...
  • Develi S, Evran B, Betül Kalaz E, Koçak-Toker N, Erata ...
  • Dogrul A, Zagli U, Tulunay FC. 2002. The role of ...
  • Dollah MA, Parhizkar S, Izwan M. 2013. Effect of Nigella ...
  • Doyle T, Bryant L, Batinic-Haberle I, Little J, Cuzzocrea S, ...
  • Ezz HSA, Khadrawy YA, Noor NA. 2011. The neuroprotective effect ...
  • Gilhotra N, Dhingra D. 2011. Thymoquinone produced antianxiety-like effects in ...
  • Han Y, Jiang C, Tang J, Wang C, Wu P, ...
  • Hobbenaghi R, Javanbakht J, Sadeghzadeh S, Kheradmand D, Abdi FS, ...
  • Hosseinzadeh H, Fazly Bazzaz BS, Haghi MM. 2007. Antibacterial activity ...
  • Hosseinzadeh H, Parvardeh S, Asl MN, Sadeghnia HR, Ziaee T. ...
  • Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, Mansouri MT. 2005. Intra-cerebroventricular ...
  • Hosseinzadeh H, Parvardeh S. 2004. Anticonvulsant effects of thymoquinone, the ...
  • Imenshahidi M, Hosseinzadeh H, Es haghian A. 2007. Effects of ...
  • Ismail N, Ismail M, Mazlan M, Latiff LA, Imam MU, ...
  • Jrah-Harzallah H, Ben-Hadj-Khalifa S, Almawi WY, Maaloul A, Houas Z, ...
  • Jrah-Harzallah H, Grayaa R, Kharoubi W, Maaloul A, Hammami M, ...
  • Khan A, Vaibhav K, Javed H, Khan MM, Tabassum R, ...
  • Leong XF, Rais Mustafa M, Jaarin K. 2013. Nigella sativa ...
  • Mansouri MT, Naghizadeh B, Ghorbanzadeh B. 2014. Ellagic acid enhances ...
  • Mathur ML, Gaur J, Sharma R, Haldiya KR. 2011. Antidiabetic ...
  • Norfazlina MN, Farida Zuraina MY, Rajab NF, Mohd Nazip S, ...
  • Özek M, Üresin Y, Güngör M. 2003. Comparison of the ...
  • Park HS, Lee HY, Kim YH, Park JK, Zvartau EE, ...
  • Parvardeh S, Fatehi M. 2003. Effects of thymoquinone, the major ...
  • Parvardeh S, Fatehi M. 2007. Inhibitory effects of thymoquinone, the ...
  • Pasternak GW. 2001. Insights into mu opioid pharmacology; the role ...
  • Radad K, Hassanein K, Al-Shraim M, Moldzio R, Rausch WD. ...
  • Sayed AA. 2012. Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy ...
  • Seth V, Upadhyaya P, Moghe V, Ahmad M. 2011. Role ...
  • Shimatani T, Adachi H, Mihashi H, Usumoto N, Yoshimoto K, ...
  • Shippenberg TS, Zapata A, Chefer VI. 2007. Dynorphin and the ...
  • Sultan MT, Butt MS, Karim R, Iqbal SZ, Ahmad S, ...
  • Sultan MT, Butt MS, Karim R, Zia-Ul-Haq M, Batool R, ...
  • Suzuki T, Tsuda M, Narita M, Funada M, Mizoguchi H, ...
  • Tabatabai SM, Dashti S, Doosti F, Hosseinzadeh H. 2014. Phytotherapy ...
  • Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, ...
  • Tejwani GA, Rattan AK, Sribanditmongkol P, Sheu M-J, Zuniga J, ...
  • Tejwani GA, Sheu M-J, Sribanditmongkol P, Satyapriya A. 1998. Inhibition ...
  • brain and spinal cord. Brain Res, 797: 305-312. ...
  • Tembhurne SV, Feroz S, More BH, Sakarkar DM. 2014. A ...
  • Tsuji M, Takeda H, Matsumiya T, Nagase H, Yamazaki M, ...
  • Vogel HG. 2008. Drug Discovery and Evaluation: Pharmacological Assays, pp. ...
  • Zarrindast MR, Mousa-Ahmadi E. 1999. Effects of GABAergic system on ...
  • Zarrindast MR, Torkaman-Boutorabi A. 2003. Effects of imipramine on the ...
  • Ziaee T, Moharreri N, Hosseinzadeh H. 2012. Review of pharmacological ...
  • نمایش کامل مراجع